[1]
Amra Adrovic et al. 2023. The impact of COVID-19 on clinical course and treatment among patients with juvenile systemic sclerosis. Archives of Rheumatology. 38, 2 (Jun. 2023), 267–273. DOI:https://doi.org/10.46497/ArchRheumatol.2023.9636.